Dilution of molecular-pathologic gene signatures by medically associated factors might prevent prediction of resection status after debulking surgery in patients with advanced ovarian cancer.-Reference-Cited by-同舟云学术

Dilution of molecular-pathologic gene signatures by medically associated factors might prevent prediction of resection status after debulking surgery in patients with advanced ovarian cancer.

Published:2019-09-16 Issue: Volume: Page:clincanres.1741.2019
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Heitz Florian,Kommoss Stefan,Tourani Roshan,Grandelis Anthony,Uppendahl Locke^ORCID,Aliferis Constantin,Burges Alexander^ORCID,Wang Chen^ORCID,Canzler Ulrich,Wang Jinhua,Belau Antje,Prader Sonia,Hanker Lars,Ma Sisi,Ataseven Beyhan,Hilpert Felix,Schneider Stephanie,Sehouli Jalid,Kimmig Rainer,Kurzeder Christian,Schmalfeldt Barbara,Braicu Elena I.,Harter Philipp,Dowdy Sean C.,Winterhoff Boris J.,Pfisterer Jacobus,du Bois Andreas

Funder

No funder of this manuscript in charge

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models;International Journal of Clinical Oncology;2024-05-20

2. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease;npj Genomic Medicine;2024-03-05

3. Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes;Cell Reports Medicine;2023-06

4. Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas;Cancer Medicine;2023-05-16

5. Predictors of residual disease after debulking surgery in advanced stage ovarian cancer;Frontiers in Oncology;2023-01-24